Project Grant HT94252410238
Award Date
4/1/24
Completion Date
3/31/28
Dollars Obligated
$8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...
This $630,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports The Ohio State University's research to develop a targeted antibody and immunotoxin combination therapy to improve treatment of T-cell lymphoma. The award period is from July 15, 2023 to July 14, 2025. This research aims to transform health care for Service Members and the American public through innovative and impactful medical solutions for the...
The Ohio State University will receive $1,181,604 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The funding will support research into developing new methods to access extracellular vesicle MDM2 DNA cargo as a potential biomarker for liposarcoma. The grant aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for...
The U.S. Department of Defense (DoD) Defense Health Agency awarded a $1,820,004 Project Grant to Case Western Reserve University's Office of Research Administration Division, doing business as the University Hospitals of Cleveland, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," will support the development of an innovative nanoparticle-based...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
The U.S. Defense Health Agency has awarded a $1,181,250 Project Grant to The Ohio State University to conduct research on "MIF Inhibition and Glucocorticoid Therapeutics as Synergistic Treatment to Promote Neuronal Survival in Traumatic Retinal Injury" over the period from November 1, 2024 to October 31, 2027. This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports a range of biomedical research initiatives aimed at improving...
The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...
The U.S. Defense Health Agency awarded a $1,225,245 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiovascular Risk Profiling of Deployment-Related Respiratory Disease: A Translational Approach". The grant will fund a 3-year research project from November 1, 2024 to October 31, 2027 focused on investigating medical solutions for addressing cardiovascular conditions associated with...
This Project Grant award of $717,896.00 was provided by the Defense Health Agency to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420). The purpose of the award is to conduct research on prebiotic and probiotic interventions for the treatment of traumatic brain injury (TBI)-induced microbiome dysfunction. The Ohio State University is the prime awardee, and they have issued a $XXX,XXX subaward to the Research Institute at Nationwide Children's...
The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports...